- Home
- INTS vs FLYE Comparison
INTS vs FLYE Comparison
Compare INTS & FLYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- FLYE
- Stock Information
- Founded
- INTS 2012
- FLYE 2018
- Country
- INTS United States
- FLYE United States
- Employees
- INTS N/A
- FLYE N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- FLYE Aerospace
- Sector
- INTS Health Care
- FLYE Industrials
- Exchange
- INTS Nasdaq
- FLYE Nasdaq
- Market Cap
- INTS 8.7M
- FLYE 10.2M
- IPO Year
- INTS 2023
- FLYE 2024
- Fundamental
- Price
- INTS $0.50
- FLYE $0.52
- Analyst Decision
- INTS Strong Buy
- FLYE
- Analyst Count
- INTS 3
- FLYE 0
- Target Price
- INTS $8.50
- FLYE N/A
- AVG Volume (30 Days)
- INTS 396.2K
- FLYE 117.4K
- Earning Date
- INTS 05-13-2025
- FLYE 05-23-2025
- Dividend Yield
- INTS N/A
- FLYE N/A
- EPS Growth
- INTS N/A
- FLYE N/A
- EPS
- INTS N/A
- FLYE N/A
- Revenue
- INTS N/A
- FLYE $28,547,111.00
- Revenue This Year
- INTS N/A
- FLYE N/A
- Revenue Next Year
- INTS N/A
- FLYE N/A
- P/E Ratio
- INTS N/A
- FLYE N/A
- Revenue Growth
- INTS N/A
- FLYE N/A
- 52 Week Low
- INTS $0.50
- FLYE $0.33
- 52 Week High
- INTS $5.28
- FLYE $7.62
- Technical
- Relative Strength Index (RSI)
- INTS 18.57
- FLYE N/A
- Support Level
- INTS $0.46
- FLYE N/A
- Resistance Level
- INTS $0.59
- FLYE N/A
- Average True Range (ATR)
- INTS 0.05
- FLYE 0.00
- MACD
- INTS 0.02
- FLYE 0.00
- Stochastic Oscillator
- INTS 21.14
- FLYE 0.00
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About FLYE Fly-E Group Inc. Common Stock
Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.